Tradestie Institutional Equity Comparison Engine
MPLT vs TSHA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TSHA Overall Edge
TSHA Captures Institutional Edge (3โ0 Pillars ยท 6โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Taysha Gene Therapies, Inc. Common Stock (TSHA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MPLT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus TSHA at N/M Forward P/E and -2998.0% operating margin (+171.3% YoY). In options structure, MPLT sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro) against TSHA sits in BREAKDOWN (34th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
MPLT N/M vs TSHA N/M Fwd P/E
Growth & Margin Winner
TSHA
Op Margin 0.0% vs -2998.0% ยท YoY +0.0% vs +171.3%
Momentum & Technical Winner
TSHA
1Y -59.3% vs -7.2% ยท 52W Pos 0% vs 7%
Options & Structure Winner
TSHA
BREAKDOWN (9th %ile IV) vs BREAKDOWN (34th %ile IV)
MPLT
US Equity
MapLight Therapeutics, Inc.
Pharmaceutical Preparations
$5.94
-7.48% 1D
Market Cap
$356.8M
1M Return
-28.0%
1Y Return
-59.32%
Forward P/E
N/M
Unified AI Score
48.3 / 100
HOLD
Tech 33.0
Fund 64.0
Flow 67.0
Mom 64.0
TSHA
NASDAQ
Taysha Gene Therapies, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$3.72
-1.33% 1D
Market Cap
$1.2B
1M Return
-7.12%
1Y Return
-7.23%
Forward P/E
N/M
Unified AI Score
49.8 / 100
HOLD
Tech 25.0
Fund 51.0
Flow 69.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MPLT -59.32%
TSHA -7.23%
Spread: +52.09 pp (TSHA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MPLT TTM Op. Margin: 0.0%
TSHA TTM Op. Margin: -2998.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MPLT vs TSHA. Trailing 12-month operating profitability (MPLT 0.0% vs TSHA -2998.0%) and valuation multiples (MPLT N/M vs TSHA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MPLT | TSHA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $356.8M | $1.2B | Larger Scale | TSHA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +171.3% | Higher Growth | TSHA |
| Operating Margin (TTM) Profitability | 0.0% | -2998.0% | Higher Margin | MPLT |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -74.2% | -54.2% | Higher ROE | TSHA |
| 52-Week Range Position Momentum | 0% ($6โ$40) | 7% ($3โ$7) | Stronger Trend | TSHA |
| Beta / 30D Volatility Risk Regime | 1.19ฮฒ ยท 79% Vol | 1.81ฮฒ ยท 52% Vol | Lower Realized Risk | TSHA |
| Unified Institutional Score Composite Signal | 48.3 / 100 (HOLD) | 49.8 / 100 (HOLD) | Higher Composite | TSHA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MPLT vs TSHA Buy Guide
MPLT
BREAKDOWN
148d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
9th %ile
IV Regime
Compressed (<25th %ile)
TSHA
BREAKDOWN
138d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
34th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MPLT nor TSHA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.